| NCT06681766 | A Study to Assess Nomlabofusp in Adolescents and Children with Friedreich's Ataxia | RECRUITING | PHASE1 | 2024-12-06 | 2025-08 | 2025-08 |
| NCT06447025 | An Open Label Extension Study of CTI-1601 in Subjects With Friedreich's Ataxia | ENROLLING_BY_INVITATION | PHASE2 | 2024-01-25 | 2027-01 | 2027-01 |
| NCT05579691 | A Double-Blind, Placebo-Controlled, Dose Exploration Study of CTI-1601 in Adult Subjects With Friedreich's Ataxia | COMPLETED | PHASE2 | 2022-09-21 | 2023-12-04 | 2023-12-04 |
| NCT04519567 | Multiple Ascending Dose Study of CTI-1601 Versus Placebo in Subjects With Friedreich's Ataxia | COMPLETED | PHASE1 | 2020-07-31 | 2021-03-16 | 2021-03-16 |
| NCT04176991 | Single Ascending Dose Study of CTI-1601 Versus Placebo in Subjects With Friedreich's Ataxia | COMPLETED | PHASE1 | 2019-12-11 | 2020-10-31 | 2020-10-31 |